These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10371847)

  • 21. Influence of multiple risk factors on the hazard of hypertension.
    Kannel WB
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S53-7. PubMed ID: 11527137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors of cardiovascular diseases, cerebral hemodynamics and psychological features of personality: correlation in young males depending on prognosis of essential hypertension].
    Pravilo VS; Belov VV
    Ter Arkh; 2007; 79(1):43-6. PubMed ID: 17385463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular arrhythmias: Q-T prolongation and left ventricular hypertrophy in adult Nigerians with hypertensive heart disease.
    Opadijo OG; Omotoso AB; Araoye MA
    Niger Postgrad Med J; 2003 Jun; 10(2):76-8. PubMed ID: 14567039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in ST segment on ECG of hypertensive patients].
    Riabykina GV; Liutikova LN; Saidova MA; Botvina IuV; Kozhemiakina ESh; Shchedrina EV; Sobolev AV
    Ter Arkh; 2008; 80(5):67-73. PubMed ID: 18590119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of prolonged ventricular repolarization in hypertension.
    Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
    Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respective impacts of aortic stenosis and systemic hypertension on left ventricular hypertrophy.
    Garcia D; Pibarot P; Kadem L; Durand LG
    J Biomech; 2007; 40(5):972-80. PubMed ID: 16750211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
    Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
    Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arterial hypertension and ischemic cardiopathy].
    Falcão LM
    Rev Port Cardiol; 1992 Mar; 11(3):247-53. PubMed ID: 1535204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Conditions leading patients to the hypertensive cardiac units].
    Sánchez Domínguez J
    Rev Esp Cardiol; 1997; 50 Suppl 4():18-23. PubMed ID: 9411583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease.
    Frohlich ED
    Braz J Med Biol Res; 2000 Jun; 33(6):693-700. PubMed ID: 10829097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of interaction between left ventricular dysfunction and endothelial function in hypertension.
    Sciacqua A; Borrello F; Vatrano M; Grembiale RD; Perticone F
    Curr Hypertens Rep; 2006 Jun; 8(3):212-8. PubMed ID: 17147919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.